Correlations of severity of coronary artery disease with levels of interleukin-6 and interleukin-17 in rheumatoid arthritis patients complicated with coronary heart disease

DENG Yifan; ZHANG Jing; ZHOU Wei

doi:10.7619/jcmp.20214376

Journal of Clinical Medicine in Practice > 2022 > 26(3): 55-58. > DOI: 10.7619/jcmp.20214376

DENG Yifan, ZHANG Jing, ZHOU Wei. Correlations of severity of coronary artery disease with levels of interleukin-6 and interleukin-17 in rheumatoid arthritis patients complicated with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 55-58. DOI: 10.7619/jcmp.20214376

Citation:

PDF (517 KB)

Correlations of severity of coronary artery disease with levels of interleukin-6 and interleukin-17 in rheumatoid arthritis patients complicated with coronary heart disease

1.
Department of Cardiovascular Medicine, Clinical Medical College of Yangzhou University, Subei People's Hospital, Yangzhou, Jiangsu, 225001
2.
Department of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, 225001

More Information

Received Date: November 05, 2021
Available Online: March 10, 2022
Published Date: February 14, 2022

Graphical Abstract

Abstract

Abstract

Objective To investigate the correlations of the severity of coronary artery disease with the levels of interleukin-6 (IL-6) and interleukin-17 (IL-17) in rheumatoid arthritis (RA) patients complicated with coronary heart disease (CHD).
Methods A total of 30 RA patients complicated with CHD were selected as RA combined with CHD group, 30 patients with simple CHD were selected as CHD group, and 30 patients with simple RA were selected as RA group. The levels of IL-6 and IL-17 in the three groups were detected by flow cytometry, and the relationships between IL-6, IL-17 and Gensini score were analyzed.
Results Gensini score of coronary artery in the RA combined with CHD group was (42.63±27.30) points, which was significantly higher than (29.17±22.07) points in the CHD group (P < 0.05). The levels of IL-6 and IL-17 in the RA combined with CHD group were significantly higher than those in the RA group and the CHD group, and the levels of IL-6 and IL-17 in the RA group were significantly higher than those in the CHD group (P < 0.05). Pearson correlation analysis showed that Gensini score was positively correlated with IL-6 and IL-17 levels (r=0.351, 0.545, P=0.006, 0.001).
Conclusion Based on no differences in the course and activity of RA, the levels of IL-6 and IL-17 in peripheral blood and the severity of coronary artery disease in RA patients with CHD are higher and greater than those in single RA patients and single CHD patients.
- rheumatoid arthritis,
- coronary heart disease,
- coronary artery,
- interleukin-6,
- interleukin-17,
- correlation

FullText(HTML)

References (18)

References

[1]	WOUDE D, ANNETTE H M, VAN DER HELM-VAN MIL. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis[J]. Best Pract Res Clin Rheumatol, 2018, 32(2): 174-187. doi: 10.1016/j.berh.2018.10.005
[2]	BLUM A, ADAWI M. Rheumatoid arthritis (RA) and cardiovascular disease[J]. Autoimmun Rev, 2019, 18(7): 679-690. doi: 10.1016/j.autrev.2019.05.005
[3]	FRANSEN J, VAN RIEL P L. The Disease Activity Score and the EULAR response criteria[J]. Rheum Dis Clin North Am, 2009, 35(4): 745. doi: 10.1016/j.rdc.2009.10.001
[4]	CONFORTI A, DI COLA I, PAVLYCH V, et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis[J]. Autoimmun Rev, 2021, 20(2): 102735. doi: 10.1016/j.autrev.2020.102735
[5]	HANNAWI S, HANNAWI H, AL SALMI I. Cardiovascular disease and subclinical atherosclerosis in rheumatoid arthritis[J]. Hypertens Res, 2020, 43(9): 982-984. doi: 10.1038/s41440-020-0483-4
[6]	KLINGENBERG R, LüSCHER T F. Rheumatoid arthritis and coronary atherosclerosis: two cousins engaging in a dangerous liaison[J]. Eur Heart J, 2015, 36(48): 3423-3425. doi: 10.1093/eurheartj/ehv489
[7]	BŁYSZCZUK P, SZEKANECZ Z. Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis[J]. RMD Open, 2020, 6(1): e001032. doi: 10.1136/rmdopen-2019-001032
[8]	CHOY E H S, CALABRESE L H. Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis[J]. Rheumatology (Oxford), 2018, 57(11): 1885-1895. doi: 10.1093/rheumatology/kex391
[9]	BOLURI A, KHAZAEI H, SARGOLZAEI N, et al. The comparison of IL-17 levels in patients with unstable angina before and after medical treatment[J]. Human Antibodies, 2021(Suppl): 1-5.
[10]	WANG M, WEI J, LI H, et al. Leptin Upregulates Peripheral CD4⁺CXCR5⁺ICOS⁺ T Cells via Increased IL-6 in Rheumatoid Arthritis Patients[J]. J Interferon Cytokine Res, 2018, 38(2): 86-92. doi: 10.1089/jir.2017.0031
[11]	KAMEL K M, GAD A M, MANSOUR S M, et al. Novel Anti-arthritic Mechanisms of Polydatin in Complete Freund's Adjuvant-Induced Arthritis in Rats: Involvement of IL-6, STAT-3, IL-17, and NF-кB[J]. Inflammation, 2018, 41(5): 1974-1986. doi: 10.1007/s10753-018-0841-4
[12]	CHANG L, FENG X, GAO W. Proliferation of rheumatoid arthritis fibroblast-like synoviocytes is enhanced by IL-17-mediated autophagy through STAT3 activation[J]. Connect Tissue Res, 2019, 60(4): 358-366. doi: 10.1080/03008207.2018.1552266
[13]	PAULI N, PUCHAŁOWICZ K, KULIGOWSKA A, et al. Associations between IL-6 and Echo-Parameters in Patients with Early Onset Coronary Artery Disease[J]. Diagnostics (Basel), 2019, 9(4): 189. doi: 10.3390/diagnostics9040189
[14]	GAGER G M, BIESINGER B, HOFER F, et al. Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome[J]. Vascul Pharmacol, 2020, 135: 106806. doi: 10.1016/j.vph.2020.106806
[15]	YAZDANI M R, KHOSROPANAH S, DOROUDCHI M. Interleukin-17 production by CD4⁺CD45RO⁺Foxp3⁺ T cells in peripheral blood of patients with atherosclerosis[J]. Arch Med Sci Atheroscler Dis, 2019, 4: e215-e224.
[16]	WAN Q, LIU Z Y, YANG M, et al. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4⁺ CD25⁺ Foxp3⁺ regulatory T cells[J]. Toxicol Lett, 2019, 316: 27-34. doi: 10.1016/j.toxlet.2019.09.005
[17]	BŁYSZCZUK P, SZEKANECZ Z. Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis[J]. RMD Open, 2020, 6(1): e001032. doi: 10.1136/rmdopen-2019-001032
[18]	ATZENI F, TALOTTA R, MASALA I F, et al. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents[J]. Best Pract Res Clin Rheumatol, 2018, 32(4): 500-510.

Cited By

Cited by

Periodical cited type(4)

1.	沈利娜，邵海燕，骆晓婷，陈珊. 预防性应用头孢曲松和喹诺酮对高龄前列腺穿刺术患者全身炎症反应综合征的效果比较及影响因素. 中国药物与临床. 2024(05): 298-301 .
2.	王书恒，李九智，高阳，刘彼得，雷鹏. 前列腺增生患者TUPKRP术后发生全身炎症反应综合征的危险因素分析. 保健医学研究与实践. 2024(07): 79-82+108 .
3.	宋先初，刘明勋，蒋智. 次氯酸冲洗液预防经尿道前列腺电切术后感染的临床研究. 系统医学. 2024(22): 75-77 .
4.	甘育涛，陈佳青. 右美托咪定辅助腰硬联合麻醉对老年经尿道前列腺电切术患者应激反应及炎症因子的影响. 药品评价. 2023(06): 769-772 .

Other cited types(0)

Get Citation

PDF

XML

Article views PDF downloads Cited by(4)

Turn off MathJax

Article Contents

Abstract

References

Correlations of severity of coronary artery disease with levels of interleukin-6 and interleukin-17 in rheumatoid arthritis patients complicated with coronary heart disease

Abstract

References

Cited by

Periodical cited type(4)

Other cited types(0)

Catalog

Export File

Citation

Format

Content